Latest Michael Baum Stories
Michael Baum, Professor emeritus of surgery at University College London says that, while deaths from breast cancer may be avoided, any benefit will be more than outweighed by deaths due to the long term adverse effects of treatment.
Results from the longest-running trial comparing tamoxifen with the aromatase inhibitor letrozole show unequivocally that letrozole has withstood the test of time and continues to prevent breast cancer recurrences and reduce the risk of death in post-menopausal women with hormone receptor-positive early breast cancer.
LAS VEGAS, May 10, 2011 /PRNewswire/ -- Interop Booth# 627 -- Mu Dynamics, Inc. (www.mudynamics.com), the leader in validating and testing application-aware networks, today announced Michael Baum, the founding CEO of Splunk has joined its board of directors.
By Anthony J. Brown, MD NEW YORK (Reuters Health)
By Nick Smith and Arjen Peters LONDON (Agence de